Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin subunit alpha 6 is a cell-surface protein encoded by the ITGA6 gene. It functions as part of two major heterodimeric integrin receptors: alpha-6/beta-4, which is critical for the structural stability of epithelia and forms hemidesmosomes anchoring the epidermis, and alpha-6/beta-1, implicated in developmental tissue morphogenesis[1][2][4][6][7]. Both heterodimers act as receptors for laminins, mediating cell-matrix adhesion, signal transduction, and regulation of cell proliferation, survival, and migration[1][4][6][7]. Alterations in integrin alpha-6 expression or function are linked to several pathological states, including carcinoma progression and rare genetic skin disorders, underscoring its dual importance in tissue integrity and as a potential therapeutic target[2][4][5].
Inhibition of cell adhesion and migration by blocking the interaction between integrin alpha-6 and its ligands (e.g., laminins) Disruption of signaling pathways involved in metastasis and proliferation (preclinical research)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin subunit alpha 6 (ITGA6).